The product is a long-acting human insulin analogue. It is produced using recombinant DNA technology in yeast cells. This insulin analogue has a 14-C fatty acid, myristic acid, bound to the lysine amino acid at position B29. The myristoyl side chain increases self-association and albumin binding. 169148-63-4 https://www.creativebiomart.net/therapeutic-proteins/p/126/human-insulin-analogue-has-a-14-c-fatty-acid-myristic-acid-bound-to-the-lysine-amino-acid-at-position-b29/
